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Summary 
Apoptosis (programmed cell death) of T lymphocytes has been proposed as a mechanism which 
plays an important role in the pathogenesis of human immunodeficiency virus (HIV) disease. 
Activation of Fas (CD95) can either result in costimulation of proliferation and cytokine production 
or in the induction of apoptosis of T lymphocytes. This raises the possibility that Fas is involved 
in the observed T  cell apoptosis during HIV disease. In this report we show that peripheral 
blood CD4+  and CD8+  T lymphocytes from HIV-infected individuals undergo apoptosis in 
vitro in response to antibody stimulation (cross-linking)  of Fas at a much higher frequency than 
from uninfected controls. This anti-Fas-induced T cell apoptosis is markedly higher than spontaneous 
T cell apoptosis in HIV-infected individuals. Antibodies against other members of the tumor 
necrosis factor (TNF)/nerve growth factor receptor family such as CD27, CD30, CD40, 4-1BB, 
p55 TNF receptor,  p75 TNF receptor,  and TNF receptor-related protein did not result in any 
increase of T  cell apoptosis above that  spontaneously observed in HIV+  individuals.  Anti- 
Fas-induced apoptosis was  much higher in symptomatic HIV-infected individuals; and the 
magnitude of anti-Fas-induced CD4+  T cell apoptosis correlated inversely with peripheral blood 
CD4 +  T cell absolute counts. Surface expression of Fas on T cells was also found to be higher 
in HIV-infected individuals. Resting and activated CD4+  and CD8+  T cells both underwent 
apoptosis in response to anti-Fas antibody. L-Selectin positive memory CD4 +  T cells were especially 
susceptible  to  anti-Fas-induced apoptosis. These findings show that  CD4+  and  CDS+  T 
lymphocytes in HIV-infected individuals are primed in vivo to undergo apoptosis in response 
to Fas stimulation, suggesting that Fas signaling may be responsible for the T lymphocyte  functional 
defects and depletion observed in HIV disease. 
S 
Pontaneous and activationqnduced T cell apoptosis (pro- 
grammed  cell  death)  has  been  well-documented  in 
peripheral blood mononuclear cell cultures of HIV-infected 
individuals (1-3) and has been proposed as a mechanism in- 
volved in both the functional T  cell defects observed even 
at early stages of the disease and the later depletion of T lym- 
phocytes (4). The mechanisms however involved in this apop- 
tosis  have not yet been elucidated.  Fas, a member of the 
TNF/nerve growth factor (NGF) 1 receptor superfamily (5), 
and its ligand (FasL) have recently been cloned (6, 7), and 
signaling through Fas has been shown to induce apoptosis 
of transformed cell lines and chronically activated T cell clones 
and lines (8-10). On peripheral blood T cells of healthy indi- 
viduals, however, Fas acts as a costimulating receptor enhancing 
proliferation and cytokine production (10). Cytotoxic T lym- 
1 Abbreviations used in this paper: NGF, nerve growth factor;  TNFRrp, 
TNF receptor-related protein. 
phocytes have recently been shown to use both the perforin 
system and Fas-FasL interactions to kill their target cells, in- 
cluding viraUy infected cells (11, 12). These observations raise 
the question whether Fas is involved in T cell apoptosis of 
HIV disease. 
In this study we examined whether Fas stimulation by cross- 
linking with monoclonal antibodies induces peripheral blood 
T cell apoptosis in HIV-infected individuals. We found that 
Fas induces marked T cell apoptosis in HIV-infected individ- 
uals. In contrast, antibodies against other members of the 
TNF/NGF receptor family, such as CD27, CD30, CD40, 
4-1BB, p55  TNF receptor,  p75 TNF receptor,  and TNF 
receptor-related protein (TNFRrp) all failed to induce apop- 
tosis. Anti-Fas-induced apoptosis involved both CD4+  and 
CD8+  T cells and correlated with disease progression and 
severity. These findings indicate that Fas/Fas ligand interac- 
tions may play an important role in T cell apoptosis and there- 
fore the pathogenesis of HIV disease. 
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Samples and Reagents.  Heparinized  blood samples were obtained 
after informed consent of HIV+  (n  =  79) and HIV-  (n  =  16) 
individuals. Patients were characterized as symptomatic (n = 48) 
when presented with Kaposi's sarcoma or opportunistic infections. 
Mouse monoclonal antibodies to Fas antigen (M3, M38, and M33, 
all IgG1 isotypes), anti-CD27 (M48), anti-CD30 (M44 and M67), 
anti-CD40 (M3), anti-4-1BB (M127), anti-p55 TNF receptor (MS0), 
anti-p75 TNF receptor (M1), and anti-TNF receptor-related pro- 
tein (M12) were provided by Immunex Corp., Seattle, WA. Anti- 
CD3 monoclonal antibody OKT3 and the isotype control anti- 
body DS-1 (anti-mouse IgM of the a allotype)  were kindly provided 
by Drs. M. Feldmann, Kennedy Institute, London, UK, and A. B. 
Kantor, Dept.  of Genetics, Stanford, respectively. 
Anti-FasStimulationandApoptosisMeasureraent.  Freshly  isolated 
PBMCs from HIV+ and HIV- individuals  were cultured for 24 h 
at 1 x  106 cells/ml in RPMI 1640 +  10% FCS in 24-well plates 
coated with or without monoclonal anti-Fas antibody M3 or iso- 
type control IgGl monoclonal antibody DS-1. Plates were coated 
with 500 #l/well of 10 #g/ml of antibodies in RPMI 1640 for 2 h 
at 37~  plates were then washed twice briefly with 500 #l/well 
RPMI 1640 10% FCS and then washed one more time as above 
for 30 rain at 37~  In six HIV+  individuals cells were incubated 
in plates coated with antibodies to Fas, CD27, CD40, 4-1BB, p55 
TNFR, p75 TNFR, TNFR.rp, and DS-1. Apoptosis was deter- 
mined by staining ceils with 1/~g/ml Hoechst 33342 (HO342; 
Molecular Probes, Eugene, OR) for 7 min on ice (13). Cells were 
costained with anti-CD3-PE (Becton Dickinson and Co., Moun- 
tain View, CA), anti-CDS-FITC (PharMingen, San Diego, CA) 
and anti-CD4-CyChrome 5 (CyS) (PharMingen) for 15 rain on 
ice. After fixing in paraformaldehyde,  30,000 cells were analyzed 
by flow cytometry using a Facstar  |  (Becton Dickinson and Co.) 
and Desk software (14). Apoptosis was determined by measuring 
HO342 staining cells gated on forward and side scatter for live 
lymphocytes. To verify that HO342 was indeed staining apoptotic 
cells in a number of the above experiments, cells were simultane- 
ously stained  for HO342 and Merocyanine  540 (Molecular  Probes), 
another apoptotic stain which stains  cells with loosely  packed mem- 
branes (15). This latter stain showed that all HO342 staining cells 
also stained positive for Merocyanine  540. In another set of  experi- 
ments DNA content was also measured by staining cells from the 
above cultures with hypotonic propidium iodide (16). Percentages 
of hypodiploid nuclei were close to those obtained for HO342- 
positive cells. 
DNA Fragmentation.  For DNA fragmentation analysis  PBMCs 
(2  x  106 cells) were treated with media alone, solid phase bound 
anti-Fas antibody M3, or control antibody DS-1 for 5 h. Cells were 
centrifuged and DNA was extracted by resuspending cells in 20 
#1 of 50 mM Tris-HC1 pH 8.0, 10 mM EDTA, 0.5% sodium lauryl 
sarcosylate,  0.5 mg/ml Proteinase  K, and incubating  for I h at 50~ 
RNAse was then added at 100 #g/ml and the extract was further 
digested for 1 h at 50~  DNA was run on a 2% agarose gel in 
45 mM Tris borate, i mM EDTA pH 8.0. DNA was stained with 
0.5 #g/ml ethidium bromide and visualized under UV light. 
Flow Cytometry.  T lymphocyte Fas surface expression was de- 
termined by monoclonal antibody staining and flow cytometry. 
Freshly isolated PBMCs from 24 HIV+  and 11 HIV- individuals 
were stained on ice with biotinylated monoclonal anti-Fas anti- 
body M38 or isotype control monoclonal DS-1 for 15 min, cells 
were washed twice and incubated with streptavidin-PE (Phar- 
Mingen) for 15 rain and after two washes cells were incubated for 
15 min with a biotinylated anti-PE monoclonal antibody (kindly 
provided by Dr. P. Lansdorp, The Terry Fox Laboratory  for Hema- 
tology/Oncology,  Vancouver,  Canada) (17). After two more washes 
cells were incubated with streptavidin-PE for another 5 min. These 
last two incubation steps with their washes were performed two 
more times for 5 min each. Finally cells were incubated with anti- 
CD3-FITC (Becton  Dickinson and Co.) and anti-CD4-CyChrome 
(PharMingen) or anti-CD3-FITC and anti-CDS-CyChrome (Phar- 
Mingen) for 15 rain. Cells were washed twice and fixed in 0.5% 
paraformaldehyde and analyzed as above. 
Analysis of T cell subsets for memory and activation markers 
was performed by multicolor staining of cells and flow cytometry. 
PBMCs were stained for 15 min on ice with the following combi- 
nations of monoclonal  antibodies: anti-CD3-FITC (PharMingen)/ 
anti-CD4-CyChrome/anti-HLA-DR-PE (Becton Dickinson and 
Co.), anti-CD3-FITC/anti-CD4-CyChrome/anti-CD38-PE  (Phar- 
Mingen), anti-CD3-FITC/anti-CD8-CyChrome  (PharMingen)/ 
anti-HLA-DR-PE and anti-CD3-FITC/anti-CDS-CyChrome/anti- 
CD38-PE, anti-CD4-CyChrome/anti-CD45RA-PE/anti-CD62L- 
FITC (PharMingen) or anti-CDS-CyChrome/anti-CD45RA-PE/ 
anti-CD62L-FITC (PharMingen). Cells were fixed  in paraformalde- 
hyde and analyzed as above. 
Statistical Analysis.  Data were analyzed by Mann-Whitney U 
test, Wilcoxon's signed-rank test for paired data, Student's t test, 
and Spearman's rho correlation using JMP Statistics Guide (SAS 
Institute Inc., Cary, NC). 
Results 
Anti-Fas-induced Apoptosis.  We found that cross-linking 
of Fas with solid phase (plastic bound) anti-Fas antibody (M3) 
for 24 h induces marked in vitro apoptosis of PBMC T cells 
from 79 HIV-infected individuals. Apoptosis was measured 
by a modified HO342 stain and flow cytometry (Fig.  1 A). 
All  HO342-positive  cells  (apoptotic)  double  stained  for 
Merocyanine 540,  which also stains  apoptotic cells. Apop- 
toffs induced by immobilized anti-Far antibody was  also 
confirmed by measurement of hypodiploid nuclei stained with 
hypotonic propidium iodide solution. Stimulation of PBMCs 
from HIV-infected individuals with the same anti-Fas anti- 
body on plastic for 5 h resulted in enhanced DNA fragmen- 
tation, a hallmark of apoptosis (Fig.  1 B). In PBMCs from 
HIV-negative individuals little or no DNA fragmentation 
could be shown (Fig.  1 B). The levels of anti-Fas-induced 
apoptosis in HIV-infected individuals, as assessed by HO342 
staining, were markedly higher than those spontaneously ob- 
served (Fig. 1 C). This anti-Fas-induced T cell apoptosis in 
HIV+  individuals was much higher than in HIV-negative 
controls (Fig.  1, A  and C; Table 1). This increase in apop- 
tosis observed with anti-Fas was also accompanied by a reduc- 
tion in the number of T cells recovered in culture (data not 
shown). Apoptosis could be induced by two different mouse 
monoclonal anti-Fas antibodies (M3 and M38) both of  which 
also kill the Fas-sensitive Jurkat cell line.  In PBMCs from 
some HIV+ individuals which showed very high M3-induced 
apoptosis,  a third anti-Fas monodonal antibody (M33) that 
is a weak killer of the Jurkat cell line also induced significant 
killing (data not shown). This indicates that the threshold 
for triggering Fas induced T cell apoptosis in cells from some 
HIV+  individuals is lower than that of the Jurkat cell line. 
In contrast to Fas, antibodies against CD27, CD30, CD40, 
2030  Fas-induced  T Cell Apoptosis in Human Immunodeficiency  Virus 4-1BB, p55 TNF receptor, and p75 TNF receptor on PBMCs 
from 6  HIV+  individuals  failed to induce T  cell apoptosis 
above background or control antibody induced levels  (Fig. 
2). Antibodies to TNFRrp also did not induce apoptosis (data 
not  shown). 
Figure  1.  Anti-Fas  antibody  induces  in vitro increased  levels 
of apoptosis ofCD3+ T lymphocytes  from PBMCs of HIV- 
infected individuals compared to  uninfected individuals. 
(A) Representative  experiment showing  apoptosis  in an HIV+ 
(a, b, c) and HIV- (d, e,.f) individual. 24-h culture sponta- 
neous (a, d), anti-Fas antibody-induced  (b, e) and isotype  con- 
trol antibody-induced  (c,J) apoptosis  shown. Number in upper 
right corner indicates percentage  of  CD3 + lymphocytes  that 
are apoptotic. Apoptosis  was measured  by staining cells with 
Hoechst 33342 (HO342). (B) PBMC DNA fragmentation 
is induced  by anti-Fas antibody  M3 in HIV+ individuals. Three 
HIV+ and two HIV- individuals  shown. Lane I, Untreated; 
lane 2, anti-Fas antibody treated; and lane 3, isotype control 
antibody-treated PBMC cultures. (C) Anti-Fas antibody in- 
duces marked apoptosis of peripheral blood CD3+  T lym- 
phocytes in HIV+ individuals. (Open circles) HIV+. (Closed 
circles) HIV-. Spontaneous 24-h apoptosis (groups 1 and 4), 
anti-Fas antibody (groups 2 and 5), and isotype control anti- 
body (groups 3 and 6) induced apoptosis shown. Horizontal 
solid line shows median values. Percent apoptosis of PBMC 
CD3 +  T lymphocytes  induced by anti-Fas antibody M3 is 
significantly increased in HIV+ individuals (n  =  79) com- 
pared to HIV- individuals (n  =  16) (P <0.001, determined 
by Mann-Whitney  U-test). Anti-Fas  antibody-induced  apop- 
tosis is significantly  higher than spontaneously  occurring  apoly 
tosis (P <0.001, determined by Wilcoxon's signed rank test 
for paired data). Apoptosis  in isotype  control antibody-treated 
cultures did not differ from that  spontaneously observed. 
Anti-Fas-induced apoptosis, as measured by flow cytom- 
etry,  occurred in both  the CD4+  and CD8+  T  lympho- 
cytes subpopulations (Fig. 3 A). Preliminary results suggest 
that CD8 +  T  cells may have earlier kinetics of apoptosis in- 
duction compared to the CD4+  T  cells (data not shown). 
Table  1.  Anti-Fas  Antibody-induced  Apoptosis of T  Lymphocytes 
Percent apoptosis 
CD3 +  lymphocytes  CD4 +  lymphocytes  CD8 +  lymphocytes 
HIV+  Individuals  (n  =  79): 
Asymptomatic (n  =  48): 
Symptomatic (n  =  31): 
HIV-  Individuals  (n  =  16): 
31  +  2  (28)*  45  _  3  (44)  17  +  2  (9) 
27  +_  3  (25)  38  -+  3  (35)  17  •  3  (8) 
36  •  3  (38)  56  •  4  (58)  17  •  2  (10) 
7  _+  1(5)  9  •  2 (6)  4  •  1 (3) 
* Mean  _+  SE (median). 
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by cross-linking with immobilized antibodies members of the TNF/NGF 
receptor family on PBMCs from asymptomatic HIV+ individuals. T cell 
apoptosis could be induced only by Fas antigen stimulation.  Experiment 
was repeated with six HIV+  individuals yielding  similar results. 
Spontaneous and anti-Fas-induced apoptosis of CD4 +  T cells 
from HIV+  individuals was higher in symptomatic (n  = 
31) compared to asymptomatic individuals (n =  48), whereas 
no such difference could be shown for CD8 +  T  cells (Fig. 
3 B). Spontaneous and anti-Fas  antibody induced CD4 +  T 
cell apoptosis correlated inversely with peripheral blood CD4+ 
T  cell  counts  in  both  asymptomatic  (P <0.001  in  both, 
Spearman's rho) and the total of HIV+  individuals  (P <0.001, 
Spearman's rho)  (data not shown and Fig.  4). 
Fas Surface Expression.  The percentage of Fas+  CD4+ 
T cells in freshly isolated PBMC was significantly higher in 
24 HIV+  compared with 11 HIV-  individuals (Fig.  5 A). 
However the percentage of Fas+  CD4+  T  cell in HIV+ 
individuals did not correlate with anti-Fas-induced apoptosis 
of these cells. The numbers of Fas+  CD4+  T cells also did 
not differ between symptomatic and asymptomatic HIV+ 
individuals and did not correlate with peripheral blood CD4 + 
cell counts (data not shown). 
T  Cell Surface Phenotype and Apoptosis.  The representa- 
tion  of live  (HO342-negative)  activated  (HLA-DR+  or 
CD38+)  or resting (HLA-DR-  or CD38-)  CD4+  and 
CD8 +  T cells remaining in culture after 24 h did not differ 
between control antibody and anti-Fas antibody-treated cul- 
tures of PBMCs from eight asymptomatic HIV+  individ- 
uals, indicating that activated and resting T cells populations 
both underwent apoptosis in response to anti-Fas stimula- 
tion to a similar extent (data not shown). In 13 asymptom- 
atic HIV+  individuals tested, L-selectin expressing memory 
CD4 +  T cells (CD62L+  CD45RA-) were found to be par- 
ticularly depleted in response to anti-Fas stimulation  (Fig. 
5  B).  In  these  24-h  cultures  CD62L-  CD45RA-  and 
CD62L-  CD45RA+  memory CD4+  populations  were 
spontaneously depleted (data not  shown). 
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Figure 3.  (.4) Anti-Fas antibody induces significantly higher levels of 
apoptosis of both CD4+  and CDS+  peripheral blood T  lymphocytes 
in HIV+  individuals  compared  with  HIV-  individuals  (P  <0.001, 
determined by Mann-Whitney  U-test). (Open circles) HIV+. (Closed circles) 
HIV-  individuals. Horizontal solid line indicates median. (B) Anti-Fas 
antibody-induced  CD4 +  T lymphocyte apoptosis is significantly higher 
in symptomatic (n = 31) versus asymptomatic HIV+ individuals (n =  48) 
(P <0.02,  determined  by Mann-Whimey U-test).  (Open  circles) HIV+. 
(Closed circles) HIV- individuals.  Horizontal solid lines show median values. 
Discussion 
Spontaneous and activation-induced apoptosis of T  cells 
has been proposed as a mechanism involved in both the T 
cell functional defects which are observed early on in HIV 
infection and in the depletion ofCD4+  T cells which occurs 
later (4).  Members of the TNF/NGF  receptor family have 
been shown to act as costimulants of normal peripheral blood 
T  cells inducing proliferation and cytokine production (5). 
Fas antigen in particular has also been shown to induce T 
cell apoptosis in transformed cell lines and chronically acti- 
vated T  cell lines and clones.  In this study, we found that 
stimulation of Fas antigen induces marked apoptosis of freshly 
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Figure  5.  (A) Fas expressing CD4+  T cells are significantly increased 
in HIV+  individuals (n ffi  24) compared to HIV-  individuals (n  ffi  11) 
(P <0.02,  determined by Mann-Whitney U-test). (Open circles) HIV+. 
(Closed circles) HIV- individuals. Horizontal  solid lines show median values. 
(B) Live (HO342 negative), memory and naive, CD4+ T cells in PBMC 
cultures from asymptomatic  HIV+ individuals (n ffi 13) treated with iso- 
type control or anti-Fas antibody for 24 h. CD62L+ CD45RA- CD4+ 
T cells were significantly depleted by anti-Fas treatment (P <0.001, Wil- 
coxoffs signed rank test for paired data). (Open boxes) Control antibody. 
(Closed boxes) Anti-Fas. Bars indicate mean _+. SE. Abbreviations  in graph: 
LS, CD62L; P,A, CD45RA. 
isolated PBMC CD4+  and CD8+  T cells in HIV-infected 
individuals. Although it has been reported that other members 
of the TNF/NGF receptor family, such as p55 TNF receptor, 
CD30, and 4-1BB, can induce apoptosis under certain condi- 
tions (18-20), this apoptosis of T cells in HIV-infected indi- 
viduals appears to be specific for Fas antigen. We found that 
antibodies against other TNF/NGF receptor family members 
such as CD27, CD30, CD40, 4-1BB, p55 TNF receptor, p75 
TNF receptor, and TNFRrp all failed to induce such apop- 
tosis. Spontaneous and Fas-induced apoptosis correlated in- 
versely with peripheral blood CD4+  T cell counts  in the 
overall HIV+  population  and the asymptomatic subset ex- 
amined, indicating that apoptosis may be involved in disease 
progression.  In addition Fas-induced apoptosis was higher 
in symptomatic versus asymptomatic HIV+  individuals in- 
dicating  an association with disease severity. 
Fas-expressing CD4 +  T cells were significantly increased 
in  HIV+  individuals when compared to the  HIV-  age- 
matched controls. However the percentage of Fas +  CD4 + 
T cells did not correlate  with anti-Fas antigen induced CD4+ 
T cell apoptosis. This is not surprising as no correlation be- 
tween the amount of anti-Fas-induced apoptosis and the levels 
of Fas cell surface expression has been found  (21). 
Since memory CD4+  T  cells have been reported to be 
preferentially infected in HIV-infected  individuals and this 
has been proposed as an important contributor  to the im- 
paired immune responses resulting from HIV infection (22, 
23),  we analyzed by multicolor flow cytometry T  cell sur- 
face expression of memory and activation markers (CD45RA, 
CD62L,  HLA-DK,  and CD38)  on PBMCs  treated with 
antibody  to  Fas  to  determine  which  T  cell  subsets were 
depleted. As has been previously reported for spontaneous 
apoptosis (24), activated and resting CD4+  and CDS+  T 
cells were equally susceptible to anti-Fas treatment. Memory 
T cells were more susceptible than naive cells to Fas-induced 
apoptosis.  Interestingly  L-selectin  (CD62L+)  expressing 
CD45RA-  memory CD4+  T cells, a subpopulation which 
responds potently to recall antigens and provides help for im- 
munoglobulin production and isotype switching for B cells 
(25,  26),  were found to be especially depleted in response 
to  Fas  stimulation.  During  an  in  vivo  immune  response, 
memory T cells responding to antigen may be selectively elim- 
inated, as Fas ligand would be upregulated on these cells (7, 
27) signaling apoptosis. Such Fas-mediated apoptosis in vivo 
could result in the described hyporesponsiveness to recall an- 
tigens  of HIV disease (23). 
Fas-induced apoptosis may also be involved in the described 
skewing of the immune system in favor of a Th2 like response 
which has also been proposed as a mechanism for the T cell 
defects of HIV infection (28).  Differential expression of Fas 
on Thl and Th2 type cells leads to the resistance of Th2 T 
cell clones to undergo activation-induced cell death (29). In 
HIV infection, a selective Thl depletion that involves Fas/Fas 
ligand  interactions  may  be  accountable  for  the  described 
skewing  in  favor of Th2  responses. 
In acute viral infections such as EBV infection there is high 
transient  T  cells  apoptosis which results  in a transient  ira- 
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such T cell apoptosis may play an important pathogenic role 
in AIDS. Loss of CD4+  T cells in HIV disease may be the 
net effect of a number of mechanisms acting in combination, 
i.e.,  peripheral T  cell apoptosis and loss of T  cell regenera- 
tion by the thymus. Preliminary evidence has indicated that 
in HIV infection CD4 +  and CD8 +  T cell apoptosis occurs 
in vivo in peripheral  lymph nodes (30a).  Our finding that 
peripheral blood T cells are primed in vivo to undergo apop- 
toffs in response to Fas suggests that  the peripheral lymph 
node T cell apoptosis may involve Fas/Fas ligand interactions. 
Thymocyte depletion,  on the other hand,  has been shown 
in HIV-infected human-SCID mice reconstituted with human 
fetal thymus and liver (31).  It is not known whether Fas is 
involved in this intrathymic T cell depletion. In the mouse 
the thymus expresses high levels of Fas RNA (32) although 
Fas does not appear to be involved in intrathymic clonal dele- 
tion but in peripheral T cell deletion (33).  In HIV infection 
therefore thymocytes are likely to be expressing Fas antigen, 
whether they are also primed to undergo apoptosis in response 
to Fas stimulation as peripheral blood T lymphocytes are re- 
mains to be determined. Animal models are likely to address 
this question. 
Our findings show that the Fas signal transduction pathway 
of T cells is primed to induce apoptosis in HIV-infected indi- 
viduals.  The mechanism by which HIV infection primes T 
cells to Fas-related apoptosis is not at the moment clear. HIV- 
infected cells are prone to apoptosis in response to stimula- 
tion of Fas (34), this however cannot account for the levels 
ofanti-Fas-induced T cell apoptosis which we observe, since 
by PCR only 1% of peripheral blood CD4+  T  cells are in- 
fected by the virus in HIV+ individuals (35, 36). Acute EBV 
infection can induce T  cell apoptosis, even though  B cells 
are primarily infected, and this is accompanied by increased 
Fas expression on T cells (30). Similarly,  priming of T  cells 
during HIV infection for apoptosis is more likely to be the 
result of extracdlular stimulation or viral proteins entering 
the cells and altering the Fas signal pathway. In vivo cross- 
linking of CD4 on T  calls in mice induces apoptosis which 
is mediated by Fas (37). Treatment with gp120 and antibodies 
to gp120 has also been shown to prime CD4 +  T  cells for 
activation induced apoptosis although the role of Fas has not 
been examined in this system (38, 39). This mechanism would 
directly account for anti-Fas-induced apoptosis of CD4 +  but 
not CD8 +  T cells, different mechanisms of apoptosis how- 
ever may be operative in these two subsets (40).  The possi- 
bility of other viral protein-T cell surface molecule interac- 
tions leading to Fas-mediated apoptosis such as gp120 or Tat 
and CD26 (41, 42) also cannot be excluded. Recently intra- 
cellular expression of gp160 was shown to enhance suscepti- 
bility to Fas-induced apoptosis, indicating that intracellular 
interactions with viral proteins may also be involved in this 
apoptosis priming (43). Finally,  HIV-induced alterations iv, 
the cytokine network in the form of over- or underproduc- 
tion of cytokines may also be playing a role in Fas-related 
apoptosis. 
In this study we show that CD4 +  and CD8 +  peripheral 
blood T cells from HIV-infected individuals undergo apop- 
tosis in response to stimulation  through  Fas antigen.  The 
level of CD4 +  T cell apoptosis correlates inversely with pe- 
ripheral blood CD4+  T  cell counts as well as the presence 
of symptoms thus implying an association of anti-Fas-induced 
apoptosis with disease  progression.  These findings provide 
evidence of Fas involvement in T cell apoptosis of HIV dis- 
ease, a process which may play an important role in the patho- 
genesis of the disease.  Understanding  the mechanisms of T 
lymphocyte apoptosis in HIV disease may prove of great im- 
portance not only in the design of new therapeutic approaches 
but also in vaccine development. 
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